TP53 and cancer: Although the precise relationship between reversible p53 inhibition and the sensitization of the TP53‐mutant cancer to CDDP needs to be fully disentangled by further in‐depth investigations, our results suggest that suppression of autophagy at least in part accounts for this sensitization.